— WWW.Class.Claims is pleased to announce the launch of a new website offering legal assistance to those who have suffered from defective medical devices and drugs. The legal team seeks to assist injured persons by recovering damages from the responsible corporations. A growing number of products have been identified for the injuries they have caused. Some of the best-known cases are Xarelto, Pradaxa, Taxotere, IVC filters, Invokana, Abilify, and metal on metal hip implants among others. In some instances, settlements by the corporate entities have already been made.
Xarelto blood thinner has been linked to bleeding events, including death in some cases. The drug is manufactured by Janssen Pharmaceuticals, a division of Johnson & Johnson and has been subject to thousands of legal claims. The case claims that the manufacturer failed to inform consumers and doctors of potentially serious and life-threatening side effects from Xarelto. In many instances, the victim has uncontrolled and irreversible internal bleeding.
Xarelto is prescribed to lower the risk of strokes, deep vein thrombosis (DVT), pulmonary blood clots (PE), and also embolisms. It can trigger bleeding which cannot be stopped even by medical professionals. It can cause a risk of internal blood loss. In spite of these serious adverse side effects, Xarelto has not been recalled. The claims against Xarelto state that the drug presents an unreasonable threat of injury which is not mitigated by appropriate labeling. This is also similar to another blood thinner Pradaxa.
Pradaxa is another drug which has been linked to thousands of adverse events and fatalities. When first marketed, there was no way to reverse uncontrollable bleeding caused by the drug. IVC filters have been subject to fracturing, causing serious injuries. Invokana has some hazardous side effects, including diabetic ketoacidosis( DKA), amputations, and kidney problems. Talcum powder has been linked to cases of ovarian cancer, with more than three thousand lawsuits filed against Johnson & Johnson.
Release ID: 223327